Tiziana Life Sciences Ltd. (TLSA)
Nasdaq: TLSA · Pharmaceutical Preparations · London, England, GB · filing with the SEC since 2017
Who runs Tiziana Life Sciences Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Elrifi Ivor
Chief Executive Officer. First filing Jul 2026, latest Sep 29, 2026, 2 filings in all.
Officers reporting now
2
of 3 people with a filing in the last fifteen months
Directors reporting now
1
3 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Elrifi Ivor | Chief Executive Officer | Jul 2026 | Sep 29, 2026 | none |
| Shah Keeren Rameshchandra | CHIEF OPERATING & FIN. OFFICER | May 2026 | May 22, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cerrone Gabriele M | director | Mar 2026 | Aug 7, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.